Brazil's National Health Surveillance Agency

Brazil's National Health Surveillance Agency, known by its Portuguese acronym ANVISA, is the federal regulatory body responsible for overseeing the safety, efficacy, and quality of health‑related products and services in Brazil. Its mandate encompasses the registration, monitoring, and control of medicines, vaccines, medical devices, cosmetics, sanitizers, foodstuffs, and tobacco products, ensuring that these items meet established sanitary standards before they reach consumers. ANVISA also supervises clinical trials, conducts inspections of manufacturing and distribution facilities, and evaluates adverse event reports to protect public health. The agency develops technical regulations, issues guidelines, and collaborates with international health organisations to align Brazilian standards with global best practices. Its services are directed toward both the domestic market—covering the nation’s pharmaceutical, food, and consumer goods industries—and the Brazilian population that relies on the safety of these products. By enforcing compliance through licensing, surveillance, and enforcement actions, ANVISA plays a central role in maintaining the integrity of Brazil’s health supply chain.

Headquartered in Brazil, ANVISA operates as a special autarchy under the Ministry of Health, granting it administrative and financial autonomy while remaining part of the federal executive branch. The agency’s nationwide reach is exercised through a network of regional coordination offices that implement its policies across the country’s states and municipalities. ANVISA’s distinguishing attributes include its specialised focus on health surveillance, its authority to suspend or cancel product registrations, and its capacity to issue emergency measures in response to public health threats. Notably, in September 2021, the agency’s website experienced a cyber‑attack in which hackers defaced the Traveler’s Health Declaration form, replacing it with Argentina’s flag and causing temporary service disruption, an incident that highlighted the importance of cybersecurity resilience for governmental health institutions. As a federal entity, ANVISA reports directly to the Minister of Health and is subject to oversight by legislative and judicial bodies, ensuring accountability in its regulatory functions.